site sponsored by
Tag Archive | "biogen"
Tags: biogen, biotech, exelixis, helm, james-mullen, marketplace, novel-molecules, veteran-biotech
Sources: In surprise pick, Exelixis’ Scangos named CEO of Biogen Idec
Posted on 30 June 2010
Posted in Top NewsComments (0)
Tags: abraxis, biogen, biogen-idec, biotech, diseases, drumaker, first-forray, other-diseases, summer, the-development, the-first, the-program
Aveo gets $5M payment from Biogen Idec
Posted on 14 April 2010
Posted in Top NewsComments (0)
Tags: abraxis, biogen, biologics, dendreon, drug, first-forray, other-biologics, pharmaceutical, price, provenge, sales, space, taking-the-drug, the-program
How much is too much to pay for Provenge?
Posted on 14 April 2010
Posted in Top NewsComments (0)
Tags: along-the-line, biogen, biogen-idec, boost-the-value, likes-the-idea, over-as-ceo, persistent-burr, radar, rib-x pharmaceuticals
Icahn still plotting to sell off Biogen Idec to Big Pharma
Posted on 23 March 2010
Posted in Top NewsComments (0)
Tags: biogen, biogen-idec, biotech, displeasure, likes-the-idea, News, radar, safety
Merck KGaA puts Stimuvax trial on hold after encephalitis strikes
Posted on 23 March 2010
Posted in Top NewsComments (0)
Tags: biogen, biogen-idec, board, calls-it-quits, carl icahn, david-parkinson, editor, fractious, join-the-board, people-on-icahn, single-cell, street, university
Icahn gets another seat on Biogen board and declares peace
Posted on 22 March 2010
Posted in Top NewsComments (0)
Tags: abbott-labs, acquisition, biogen, biotech, biotech deals, data, french, mergers and acquisitions, optics, percent-premium, pirfenidone, strengthen, transgene, white
Abbott buys Facet Biotech for $450M
Posted on 09 March 2010
Posted in Top NewsComments (0)
Tags: argent-capital, asked-the-board, biogen, biogen-idec, expect-the-drug, industry, masayo-tada, mullen, safety-profile, scott-harrison, sepracor, strategy
Biogen CEO calls it quits after 7 turbulent years
Posted on 05 January 2010
Posted in Top NewsComments (0)
Tags: analyst-swiftly, biogen, biogen-idec, biotech, biotech stock, boston, chief-executive, facet biotech, facet-on-two, osiris, patients, price, prochymal
Facet rejects Biogen’s $356M bid, shares rise
Posted on 08 September 2009
Posted in Top NewsComments (0)
Tags: arrangement, biogen, biogen-idec, cerezyme, commercial, competition, drug, even-as-details, larry-feinberg, management, muddy-situation, oracle, said-it-began, stakeholders, tysabri
Biogen may fight J&J-Elan deal
Posted on 03 August 2009
Posted in Top NewsComments (0)
Ask Our Experts
Heather R. Powell
Regulatory
Dawn Obermoeller
Social Media
Jonathan Richman
Non-Personal Promotion
Optimize RX
Internet Marketing & Analytics
Share Your Knowledge
We are always seeking seasoned pharmaceutical marketing professonals as contributors. If you have a strong background in pharmacetical marketing, and are interested in sharing your skills and knowledge with our community, or syndicating your existing blog posts, please click here.
- Popular
- Latest
- Comments
- Tags
- Subscribe
- Design: Flash-banner-eyebrow nightmare
- Even After Patent Cliff, Pfizer Is Undervalued
- Sanofi Board Said to Support Genzyme Bid of Up to $18.7 Billion
- FTC: âTide May Be Turningâ On Pay-To-Delay Deals
- Celgene Beats and Raises Guidance
- Who is Killing the Pharmaceutical Sales Position?
- Snafi – HCP print ad in the UAE
- Hospira plans big study for new Epogen biosimilar
- New from OSI / Astellas
- Athersys buoyed by upbeat PhI stem cell data
- Optimize RX: yep - recvd - thanks - how much daily u.v.'s r u g...
- JMB: This is another bashing article from an author who...
- Martin: It's just silly of you to obsess over the possibil...
- Gregg Feris: Jon, Thanks for the in depth reply. I like the ...
- Doc: Why should Exxon have to pay this fine for somethi...
2009
adpharm
adpharm gallery
advertising
alpha
biotech
bnet
branded
business
development
drug
DTC
english
europe
fda
fierce-biotech
fierce pharma
gallery
hcp
health
industry
internet
largest
marketing
motley-fool
News
north
north america
north_america
online
online-pharmaceutical
pharma
Print
print_ad
Regulatory
sales
seeking-alpha
single-page
Social Media
technology
the-gallery
the-largest
time
usa
wsj
Stay up to date
- Subscribe to the RSS Feed
